Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.25B | 20.36B | 20.28B | 18.94B | 17.83B | 18.30B |
Gross Profit | 62.25B | 20.36B | 20.28B | 18.94B | 17.83B | 18.30B |
EBITDA | 1.06B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 6.96B | 6.54B | 7.10B | 7.12B | 6.16B | 3.58B |
Balance Sheet | ||||||
Total Assets | 1.09T | 1.23T | 1.11T | 1.09T | 978.86B | 1.04T |
Cash, Cash Equivalents and Short-Term Investments | 142.20B | 112.99B | 146.44B | 157.53B | 141.89B | 116.27B |
Total Debt | 207.59B | 0.00 | 150.08B | 134.00B | 126.74B | 130.51B |
Total Liabilities | 1.02T | 1.16T | 1.04T | 134.00B | 126.74B | 980.99B |
Stockholders Equity | 70.31B | 69.86B | 69.52B | 65.91B | 63.66B | 61.29B |
Cash Flow | ||||||
Free Cash Flow | -1.36B | 9.95B | 5.88B | 19.52B | 43.26B | 53.08B |
Operating Cash Flow | -657.00M | 9.95B | 6.49B | 20.18B | 43.82B | 52.28B |
Investing Cash Flow | -47.74B | -42.12B | -10.69B | -1.82B | 10.26B | -11.46B |
Financing Cash Flow | -22.26B | 17.91B | 4.38B | -2.35B | -9.67B | -12.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $71.83B | 9.46 | 8.78% | 2.12% | 16.06% | 64.31% | |
76 Outperform | $76.04B | 33.01 | 24.02% | ― | 28.56% | 49.10% | |
75 Outperform | $110.97B | 9.77 | 18.07% | 4.07% | 7.86% | 17.13% | |
75 Outperform | $56.12B | 8.99 | 12.20% | 4.60% | 10.03% | 29.51% | |
73 Outperform | $77.64B | 11.98 | 12.70% | 4.49% | 1.13% | -1.14% | |
72 Outperform | $64.11B | 14.53 | 9.75% | 4.89% | 10.18% | -3.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |